Bilgehan Yüzbaşıoğlu

Bilgehan Yüzbaşıoğlu

Auto-generated profile, based on publicly available information

Bilgehan Yüzbaşıoğlu

Univ Hlth Sci Turkey, Istanbul Haseki Training & Res Hosp, Clin Gastroenterol, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
NDNurhan Demir
Nurhan Demir
BYBilgehan Yüzbasıoglu
Bilgehan Yüzbasıoglu
TCTuran Calhan
Turan Calhan
SOSavas Ozturk
Savas Ozturk
Introduction. The fibrosis 4 (FIB‐4) index was developed to predict advanced fibrosis in patients with liver disease. We aimed to evaluate the association of FIB‐4 with risk factors for progression to critical illness in middle‐aged patients hospitalized for coronavirus disease 2019 (COVID‐19). Method. We included patients aged 35–65 years who were hospitalized following a positive RT‐PCR SARS‐Cov‐2 test in a tertiary hospital. All data were obtained from the medical records of the patients during the first admission to the hospital. The FIB‐4 index was calculated according to the equation (age (years) x AST (IU/L)/platelet count (109/L)/√ALT (IU/L)). The FIB‐4 index was divided into three categories according to the score categorisation: 2.67 = high risk. Results. A total of 619 confirmed COVID‐19 patients (mean age = 52 yrs.) were included in this study; 37 (6.0%) were admitted to the intensive care unit (ICU), of which 44% were intubated and eight (1.3%) patients died during follow‐up. The results of patients with high FIB‐4 scores were compared with those with low FIB‐4 scores. In patients with high FIB‐4 scores, male gender, and advanced age, decreased neutrophil, lymphocyte, thrombocyte, and albumin counts, elevated AST, LDH, CK, ferritin, CRP, and D‐dimer, and low GFR were the high‐risk factors for critical illness. Additionally, the number of patients referred to ICU with high FIB‐4 who died had higher scores than from those with low scores. Conclusion. The FIB‐4 index derived from baseline data obtained during hospitalisation can be used as a simple, inexpensive, and straightforward indicator to predict ICU requirement and/or death in middle‐aged hospitalized COVID‐19 patients.

19 September 2023 in Bagcilar Medical Bulletin
Verified
Journal Article
Closed access
NDNurhan Demir
Nurhan Demir
BYBilgehan Yüzbaşıoğlu
Bilgehan Yüzbaşıoğlu
EKEmine Kanatsız
Emine Kanatsız
SBSaime Gül Barut
Saime Gül Barut

15 December 2019 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
BYBilgehan Yüzbaşıoğlu
Bilgehan Yüzbaşıoğlu
MUMuge Ustaoglu
Muge Ustaoglu
ŞYŞule Yüzbaşıoğlu
Şule Yüzbaşıoğlu
UAUlas Emre Akbulut
Ulas Emre Akbulut
KOKamil Ozdil
Kamil Ozdil
Background/Aims: There is an increased tendency for thrombosis and thromboembolic complications in patients with inflammatory bowel disease (IBD). The aim of the present study was to determine the serum concentrations of thrombin-activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI) and a disintegrin and metalloproteinase with thrombospondin motif-13 (ADAMTS-13) in patients with IBD and to assess their possible role in the etiopathogenesis of the disease. Materials and Methods: Thirty-four patients with IBD (23 ulcerative colitis and 11 Crohn’s disease) and 20 healthy controls were included in the present study. TAFI, TFPI, and ADAMTS-13 concentrations were determined by enzyme-linked immunosorbent assay. Results: Mean TAFI, TFPI, and ADAMTS-13 concentrations in the patient group were 17.75 ng/ml, 72.10 ng/ml, and 14.90 U/l, respectively. In the control group, these values were 117.10 ng/ml, 300 ng/ml, and 191.55 U/l, respectively. TAFI, TFPI, and ADAMTS-13 values were significantly lower in the patient group than in the control group (all p<0.01). Conclusion: TAFI, TFPI, and ADAMTS-13 levels were significantly lower in the patient group. These findings indicate the presence of a clear, multifactorial imbalance in the coagulation–fibrinolytic system in the patient group. It is also possible that this imbalance in the coagulation and fibrinolytic system may play a role in the still unclear etiopathogenesis of the disease.

27 September 2023 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
NDNurhan Demir
Nurhan Demir
BYBilgehan Yuzbasioglu
Bilgehan Yuzbasioglu